Epidemiology and Clinical Features
作者： Nikolaos Tsoukalas , Sarah Rudman
DOI: 10.1007/978-3-319-57624-4_1
关键词:
摘要: Prostate cancer is the most common non-cutaneous malignancy in Westernised countries with a lifetime risk of one seven men [1] and global incidence more than million new cases each year (Figs. 1.1 1.2) [2]. In 2012, 417,000 were diagnosed Europe highest Northern Western such as Norway (129/100,000) lowest Southeastern Albania [3]. The UK places it 17th overall an age-standardised rate 104.7 cases/100,000 1.3 1.4). It thought that widespread differences screening practices, prostate-specific antigen (PSA) testing, digital rectal examination (DRE) may explain variation country to incidence.
springer.com
sci-hub.st 参考文章(25)
Heinric Williams, Isaac J. Powell, Epidemiology, Pathology, and Genetics of Prostate Cancer Among African Americans Compared with Other Ethnicities Methods of Molecular Biology. ,vol. 472, pp. 439- 453 ,(2009) , 10.1007/978-1-60327-492-0_21
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Jacob H. Cohen, Victor J. Schoenbach, Jay S. Kaufman, James A. Talcott, Anna P. Schenck, Sharon Peacock, Michael Symons, M. Ahinee Amamoo, William R. Carpenter, Paul A. Godley, Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes & Control. ,vol. 17, pp. 803- 811 ,(2006) , 10.1007/S10552-006-0017-7
Siobhan Sutcliffe, Elizabeth A. Platz, Inflammation and prostate cancer: A focus on infections Current Urology Reports. ,vol. 9, pp. 243- 249 ,(2008) , 10.1007/S11934-008-0042-Z
Z. Levran, J.A. Gonzalez, A.C. Diokno, S.Z.H. Jafri, B.W. Steinert, Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? BJUI. ,vol. 75, pp. 778- 781 ,(1995) , 10.1111/J.1464-410X.1995.TB07390.X
G. P. Haas, W. A. Sakr, Epidemiology of prostate cancer. CA: A Cancer Journal for Clinicians. ,vol. 47, pp. 273- 287 ,(1997) , 10.3322/CANJCLIN.47.5.273
Joseph E. Oesterling, Using prostate-specific antigen to eliminate unnecessary diagnostic tests: Significant worldwide economic implications Urology. ,vol. 46, pp. 26- 33 ,(1995) , 10.1016/S0090-4295(99)80247-7
Z Kote-Jarai, , D Leongamornlert, E Saunders, M Tymrakiewicz, E Castro, N Mahmud, M Guy, S Edwards, L O'Brien, E Sawyer, A Hall, R Wilkinson, T Dadaev, C Goh, D Easton, D Goldgar, R Eeles, BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients British Journal of Cancer. ,vol. 105, pp. 1230- 1234 ,(2011) , 10.1038/BJC.2011.383
A Takenaka, R Hara, T Ishimura, T Fujii, Y Jo, A Nagai, M Fujisawa, A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer and Prostatic Diseases. ,vol. 11, pp. 134- 138 ,(2008) , 10.1038/SJ.PCAN.4500985
Theo H. Van der Kwast, Monique J. Roobol, Defining the threshold for significant versus insignificant prostate cancer. Nature Reviews Urology. ,vol. 10, pp. 473- 482 ,(2013) , 10.1038/NRUROL.2013.112